Cohort study of infectious disease risk management in Rheumatoid Arthritis patients receiving tocilizumab

Trial Profile

Cohort study of infectious disease risk management in Rheumatoid Arthritis patients receiving tocilizumab

Active, no longer recruiting
Phase of Trial: Phase II

Latest Information Update: 14 Sep 2012

At a glance

  • Drugs Tocilizumab (Primary)
  • Indications Rheumatoid arthritis
  • Focus Therapeutic Use
  • Acronyms ACT4U
  • Most Recent Events

    • 14 Sep 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top